Provided by Tiger Fintech (Singapore) Pte. Ltd.

Viking Therapeutics

32.01
-0.0600-0.19%
Post-market: 32.200.1900+0.59%19:59 EDT
Volume:3.39M
Turnover:109.42M
Market Cap:3.60B
PE:-27.76
High:33.16
Open:32.16
Low:31.28
Close:32.07
Loading ...

Viking Therapeutics Announces Initiation of Phase 3 Obesity Clinical Program With Glp-1/Gip Agonist Vk2735

THOMSON REUTERS
·
25 Jun

Viking Therapeutics Stock (VKTX): This Underrated Russell 2000 Gem Could Skyrocket 200%

TIPRANKS
·
17 Jun

Viking Therapeutics Inc. Unveils Presentation on Advancements in Obesity and Metabolic Disease Treatments

Reuters
·
14 Jun

William Blair Sticks to Its Buy Rating for Viking Therapeutics (VKTX)

TIPRANKS
·
04 Jun

Could Viking Therapeutics Become the Next Eli Lilly?

Motley Fool
·
02 Jun

Ascletis Pharma Faces Legal Setback with Seven-Year Exclusion Order for ASC41 and ASC43F Drugs

Reuters
·
30 May

Viking Therapeutics Inc. Conducted Annual Stockholders Meeting

Reuters
·
28 May

Better Weight Loss Stock: Amgen or Viking Therapeutics?

Motley Fool
·
22 May

Why Viking Therapeutics Stock Bumped 3% Higher Today

Motley Fool
·
17 May

Viking Therapeutics put volume heavy and directionally bearish

TIPRANKS
·
06 May

Why Viking Therapeutics Stock Was Victorious This Week

Motley Fool
·
03 May

Why Eli Lilly, Viking Therapeutics, and Novo Nordisk Stocks All Popped Friday

Motley Fool
·
02 May

Where Will Viking Therapeutics Be in 3 Years?

Motley Fool
·
02 May

Viking Therapeutics Inc. Unveils Corporate Presentation on Advancements in Metabolic and Endocrine Disease Therapies

Reuters
·
02 May

Will Pfizer Will Acquire Altimmune or Viking Therapeutics After Its Obesity Pill Setback?

Motley Fool
·
30 Apr

Prediction: Pfizer's Loss May Be Viking Therapeutics' Gain

Motley Fool
·
30 Apr

Why Viking Therapeutics Stock Popped Again Today

Motley Fool
·
30 Apr

Cantor Fitzgerald Initiates Viking Therapeutics at Overweight With $104 Price Target

MT Newswires Live
·
29 Apr

Viking Therapeutics Initiated at Overweight by Cantor Fitzgerald

Dow Jones
·
29 Apr

Viking Therapeutics Price Target Cut to $75.00/Share From $95.00 by Truist Securities

Dow Jones
·
28 Apr